Preclinical Development and & Jesus Mena, Ph.D. is looking to add a teammate this summer! Come grow your career at Visterra in Waltham, MA! #HiringinBiotech
Visterra Inc.
Biotechnology Research
Waltham, Massachusetts 12,210 followers
We bring better biologics to life. Biospace Best Place to Work 2024!
About us
Visterra is a clinical stage biotechnology company committed to developing innovative antibody-based therapies for the treatment of patients with kidney diseases and other hard-to-treat diseases. Our proprietary technology platform enables the design and engineering of precision antibody-based product candidates that specifically bind to, and modulate, key disease targets. Applying this technology to disease targets that are not adequately addressed by traditional therapeutic approaches, we are developing a robust pipeline of novel therapies for patients with unmet needs. Our most advanced program is in Phase 2 clinical development. In addition, Visterra has established a number of partnerships to progress novel antibodies engineered to treat significant diseases with limited treatment options.
- Website
-
http://www.visterrainc.com
External link for Visterra Inc.
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Waltham, Massachusetts
- Type
- Privately Held
- Founded
- 2008
Locations
-
Primary
Get directions
275 2nd Avenue
Waltham, Massachusetts 02451, US
Employees at Visterra Inc.
Updates
-
We're thrilled to be looking to add to our Clinical Operations team this spring! Please contact Jill Yarbrough or Nicole Akramoff to learn more about this dynamic team and/or apply here: https://lnkd.in/ewWd-Scn #Hiring #BostonBioJobs #ClinicalTrials
-
-
Congratulations to our former Co-op, Dom Pizzarella, for winning the prestigious Conduit Award at Northeastern University! The sky's the limit for you! https://lnkd.in/eBKtDSVK
-
Thrilled to introduce our newest member of the Quality Assurance team, Olga Turgeon! #hiring
-
-
We had an eventful March, including a fantastic event around St. Patrick's Day / Pi Day. We raised $1500 for the Pets and People Foundation through our pie-ings of some very brave Visterrans! #BufferZone #wearehiring #freepie
-
-
We're fortunate to have Kathryn Ellis join, bringing excellent drug development experience to Visterra! #Stillgrowing #VisterraLife #Hiring
-
-
The deadline is only 10 days away! Don’t miss the chance to apply for the Otsuka Pharmaceutical Companies (U.S.) Golden Ticket competition. Winner will get access to free lab space and membership at any BioLabs US location. Membership includes access to state-of-the-art lab equipment, exclusive events, a broad network of partners and a vibrant life science community. To learn more and to apply, visit: https://lnkd.in/eKQ_YXqq
2024 Otsuka Golden Ticket | BioLabs
biolabs.io
-
We are excited to share that Visterra has published a new paper in The Journal of Clinical Investigation describing our IL-2 mutein and transplant tolerance. This was an exciting collaboration between the researchers at Massachusetts General Hospital and the scientists at Visterra and we're enthusiastic that the work was recognized by publication in a top tier journal. Congratulations to everyone who contributed to this work! https://lnkd.in/eBY5FaNP
A humanized IL-2 mutein expands Tregs and prolongs transplant survival in preclinical models
jci.org
-
When you have two fun holidays to celebrate at the same time...this afternoon is going to be interesting! #TheBufferZone #VisterraLife #PiDay #stpatricksday
-
-
A new Visterran joined our Finance team this week! Thanks for choosing to come aboard Tyler Tiano!
-